De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

被引：0
|
作者：
Capranzano, Piera [1 ]
Angiolillo, Dominick J. [2 ]
机构：
[1] Univ Catania, Div Cardiol, CAST Policlin Hosp, Via S Sofia 78, I-95123 Catania, Italy
[2] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA
来源：
EUROINTERVENTION | 2019年 / 15卷 / 06期
关键词：
ACUTE CORONARY SYNDROME; TROPICAL-ACS; ANTIPLATELET TREATMENT; FUNCTION PROFILES; ARTERY-DISEASE; CLOPIDOGREL; OUTCOMES; THERAPY; INTERVENTION; GUIDELINES;
D O I：
10.4244/EIJV15I6A89
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E486 / E489
页数：4
相关论文
共 50 条
  • [1] Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with ACS: a meta-analysis
    Tavenier, A. H.
    Chiarito, M.
    Cao, D.
    Pivato, C. A.
    Nicolas, J.
    Nardin, M.
    Sartori, S.
    Baber, U.
    Angiolillo, D. J.
    Capodanno, D.
    Kini, A. S.
    Sharma, S. K.
    Dangas, G.
    Mehran, R.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1427 - 1427
  • [2] De-Escalation of Treatment With Oral P2Y12 Receptor Inhibitors: Current Status and Perspectives
    Alexopoulos, Dimitrios
    Lianos, Ioannis
    Vlachakis, Panagiotis
    Sfantou, Danai
    Dragona, Vassiliki-Maria
    Varlamos, Charalambos
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (04) : 304 - 314
  • [3] When will be appropriate time for P2Y12 inhibitors dose de-escalation?
    Choi, S. Y.
    Kim, M. H.
    Kim, S. J.
    Park, K. I.
    Chung, M. T.
    Lee, K. M.
    Park, J. S.
    EUROPEAN HEART JOURNAL, 2018, 39 : 350 - 350
  • [4] Unguided De-Escalation Strategy From Potent P2Y12 Inhibitors in Patients Presented With ACS: When, Whom and How
    Park, Jin Sup
    Jeong, Young-Hoon
    KOREAN CIRCULATION JOURNAL, 2022, 52 (04) : 320 - 323
  • [5] Optimizing platelet P2Y12 inhibition for patients undergoing PCI
    Steinhubl, Steven
    Roe, Matthew T.
    CARDIOVASCULAR DRUG REVIEWS, 2007, 25 (02): : 188 - 203
  • [6] P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes
    Ndrepepa, Gjin
    Kastrati, Adnan
    EUROPEAN HEART JOURNAL, 2023, 44 (15) : 1371 - 1373
  • [7] A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
    Claassens, Daniel M. F.
    Vos, Gerrit J. A.
    Bergmeijer, Thomas O.
    Hermanides, Renicus S.
    van 't Hof, Arnoud W. J.
    van der Harst, Pim
    Barbato, Emanuele
    Morisco, Carmine
    Gin, Richard M. Tjon Joe
    Asselbergs, Folkert W.
    Mosterd, Arend
    Herrman, Jean-Paul R.
    Dewilde, Willem J. M.
    Janssen, Paul W. A.
    Kelder, Johannes C.
    Postma, Maarten J.
    de Boer, Anthonius
    Boersma, Cornelis
    Deneer, Vera H. M.
    ten Berg, Jurrien M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1621 - 1631
  • [8] Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis
    Tavenier, Anne H.
    Mehran, Roxana
    Chiarito, Mauro
    Cao, Davide
    Pivato, Carlo A.
    Nicolas, Johny
    Beerkens, Frans
    Nardin, Matteo
    Sartori, Samantha
    Baber, Usman
    Angiolillo, Dominick J.
    Capodanno, Davide
    Valgimigli, Marco
    Hermanides, Renicus S.
    Hof, Arnoud W. J. van 't
    Ten Berg, Jur M.
    Chang, Kiyuk
    Kini, Annapoorna S.
    Sharma, Samin K.
    Dangas, George
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (05) : 492 - 502
  • [9] De-Escalation of Platelet P2Y12 Receptor Inhibiting Therapy After Percutaneous Coronary Intervention
    Franchi, Francesco
    Rollini, Fabiana
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (24) : 2571 - 2573
  • [10] De-escalation from potent P2Y12 inhibitors to clopidogrel: an alternative to short DAPT duration in HBR patients?
    Cayla, Guillaume
    Lattuca, Benoit
    EUROINTERVENTION, 2023, 19 (10) : E789 - E791
12345